Pharmacological correction of the hemostasis system for the surgical treatment of bitches with tumours of the mammary gland
Abstract
We carried out the clinical validation of pathogenetically substantiated protocols for the treatment of female dogs with tumour lesions of the mammary gland. The positive effect of corrective therapy was characterized by a decrease in the physiological level of fibrinogen: in benign tumours in 10 days, malignant – in 14 days against the background of its stable high level in control animals with malignant neoplasia. In the postoperative period in experimental animals, the functioning of the internal coagulation unit was restored, as evidenced by the normalization of the activated partial thromboplastin time for benign tumours by days 10–14, malignant – by 14 days. In control patients, these changes were detected only for benign neoplasms. Shifts of the external mechanism of blood coagulation in the experimental groups were eliminated in benign neoplasia cases in 10 days, malignant cases in 14 days against the background of severe disorders in this link in control patients throughout the observation period. The positive effect of complex treatment regimens is confirmed by the restoration of total fibrinolytic activity by days 10–14 due to the normalization in the same terms of the plasminogen activator and tissue plasminogen activator by days 3–7. In control animals, the total fibrinolytic activity was consistent with those of clinically healthy animals only for benign neoplasms. The balancing of coagulation and fibrinolytic mechanisms was accompanied by a decrease in the activity of proteolytic inhibitors: α2-macroglobulin in experimental groups with benign neoplasia by day 10, malignant – by days 10–14, and control – respectively, by days 3 and 14; α1-proteinase inhibitor in all groups by day 3. Concentration of nitric oxide after extirpation of benign tumors already at day 3 of the postoperative period in all groups corresponded to the indexes of clinically healthy dogs, with the removal of malignant tumours – in experimental animals at day 3, control – at day 14. The content of malondialdehyde and ceruloplasmin against the background of pharmacological correction was restored by days 10–14, whereas in control animals – only with benign neoplasms by day 14. Postoperative pharmacological correction of the hemostasis system can significantly improve the results of treatment in cancer patients.References
Andreeva, L. I., Kozhemjakin, L. A., & Kishkun, A. A. (1988). Modifikacija metoda opredelenija perekisej lipidov v teste s tiobarbiturovoj kislotoj [Modification of the method for determination of lipid peroxides in the test with thiobarbituric acid]. Laboratornoe Delo, 11, 41–43 (in Russian).
Abdullah, M. A., Almufty, B. I., Yasin, M. I., & Hassan, N. J. (2014). Clinical and histopathological study of mammary tumors in foreing dogs breeds in Kurdistan region of Iraq. Basrah Journal of Veterinary Research, 1(1), 11–19.
Astrup, T., & Mullertz, S. (1952). The fibrin plate metod for estimating fibrinolitic activity. Archives of Biochemistry and Biophysics, 40, 346–351.
Belicer, V. O., Varec'ka, T. V., & Veremjejenko, K. M. (1997). Kil'kisne vyznachennja fibrynogenu v plazmi krovi ljudyny [Quantitative determination of fibrinogen in human plasma]. Laboratorna Diagnostyka, 2, 53–55 (in Ukrainian).
Bonnett, B. N., Egenvall, A., Hedhammar, А., & Olson, Р. (2005). Mortality in over 350,000 insured Swedish dogs from 1995–2000: I. Breed-, gender-, age- and cause-specific rates. Acta Veterinaria Scandinavica, 46(3), 105–120.
Corte, M. D., Vérez, P., Rodríguez, J. C., Roibás, A., Domínguez, M. L., Lamelas, M. L., Vázquez, J., García Muñiz, J. L., Allende, M. T., González, L. O., Fueyo, A., & Vizoso, F. (2005). Tissue-type plasminogen activator (tPA) in breast cancer: Relationship with clinicopathological parameters and prognostic significance. Breast Cancer Research, 90(1), 33–40.
Dhami, M. A., Tank, P. H., Karle, A. S., Vedpathak, H. S., & Bhatia, A. S. (2010). Epidemiology of canine mammary gland tumours in Gujarat. Veterinary World, 3(6), 282–285.
Eierskyte, A., Zamokas, G., Grigonis, A., & Juodiiukyniene, N. (2011). The retrospective analysis of mammary tumors in dogs. Veterinarija ir Zootechnika, 53, 3–8.
Glazunova, L. A., & Koneva, A. V. (2014). Sravnitel'naja effektivnost' razlichnyh prijomov pri lechenii novoobrazovanij molochnoj zhelezy u sobak i koshek [Comparative effectiveness of various methods in the treatment of neoplasms of the breast in dogs and cats]. Sovremennye Problemy Nauki i Obrazovanija, 6, 18–24 (in Russian).
Golikov, P. P. (2004). Oksid azota v klinike neotlozhnyh zabolevanij [Nitric oxide in the clinic for urgent diseases]. Medpraktika, Moscow (in Russian).
Gundim, L. F., de Araújo, C. P., Blanca, W. T., Guimarães, E. C., & Medeiros, A. A. (2016). Clinical staging in femaleses with mammary tumors: influence of type and histological grade. Canadian Journal of Veterinary Research, 80(4), 318–322.
Harris, R. E., Chlebowski, R. T., Jackson, R. D., Frid, D. J., Ascenseo, J. L., Anderson, G., Loar, A., Rodabough, R., White, E., & McTiernan, A. (2003). Breast cancer and nonsteroidal anti-inflammatory drugs prospective results from the women’s health initiative. Cancer Research, 63, 6096–6101.
Korobova, N. V. (2005). Opyt primenenija Ronkolejkina na pozdnih stadijah onkologicheskih zabolevanij molochnyh zheljoz [Experience in the use of Roncoleukin in the late stages of oncological diseases of the mammary glands]. Veterinarnaja Klinika, 34, 21 (in Russian).
Levine, M. N., Lee, A. Y., & Kakkar, A. K. (2005). Thrombosis and cancer. Proceedings of the Annual Meeting of the American Society for Clinical Oncology, 13–17, 748–747.
Mischke, R., Fehr, M., & Nolte, I. (2005). Efficacy of low molecular weight heparin in a canine model of thromboplastin-induced acute disseminated intravascular coagulation. Research in Veterinary Science, 79(1), 69–76.
Mousa, S. A. (2010). Heparin and low-molecular weight heparins in thrombosis and beyond. Anticoagulants, Antiplatelets, and Thrombolytics, 663, 109–132.
Mysak, A. R. (2010). Porivnjal'ni aspekty monitoryngu neoplazij u sobak [Comparative aspects of neoplasia monitoring in dogs]. Naukovyj Visnyk Veterynarnoi' Medycyny, 76(4), 75–80 (in Ukrainian).
Owen, L. N. (Ed.). (1980). TNM classification of tumors in domestic animals. Geneva, World Health Organization.
Promzeleva, N. V., Zorina, V. N., & Zorin, N. A. (2012). Belki semejstva macroglobulinov pri rake molochnoj zhelezy [Proteins of the family of macroglobulins in breast cancer]. Voprosy Onkologii, 5, 688–690 (in Russian).
Rublenko, M. V., & Bilyj, D. D. (2012). Funkcional'ni porushennja ta systemni rozlady gemostazu za novoutvoren' u sobak [Functional disorders and systemic haemostasis disorders due to neoplasms in dogs]. Naukovo-Tehnichnyj Bjuleten', 13, 142–145 (in Ukrainian).
Rublenko, M. V., & Bilyj, D. D. (2014). Znachennja oksydantnogo stresu v patogenezi puhlyn molochnoi' zalozy u sobak [Significance of oxidative stress in the pathogenesis of breast cancer in dogs]. Problemy Zooinzhenerii' ta Veterynarnoi' Medycyny, 29(2), 75–78 (in Ukrainian).
Salman, T., Bilici, A., & Ustaalioglu, B. O. (2009). The correlation of thrombin-activated fibrinolysis inhibitor (TAFI) levels and clinicopathologic factors in advanced colorectal cancer patients. Journal of Clinical Oncology, 27, 27–32.
Talahadze, N. T., Zurrida, S., Vorotnikov, I. G., Chhikvadze, N. V., Nechushkin, M. I., Petrovskij, A. V., Paolo, A., Dzhjermana, L., Dzhuzeppe, V., Dzhjermana, L., & Umberto, V. (2012). Klassifikacija zlokachestvennyh opuholej molochnoj zhelezy po sisteme TNM: Neobhodimost' peremen [Classification of malignant tumors of the breast by the TNM system: The need for changes]. Vestnik RONC imeni N. N. Blohina, 23(1), 69–76 (in Russian).
Vareckaja, T. V., Mihajlovskaja, L. I., & Svital'skaja, L. A. (1992). Opredelenie rastvorimogo fibrina v plazme krovi [Determination of soluble fibrin in blood plasma]. Klinicheskaja Laboratornaja Diagnostika, 7–8, 10–14 (in Russian).
Veremeenko, K. N., Volohonskaja, L. I., & Kizim, A. I. (1978). Metody opredelenija prekallikrein-kallikreinovoj sistemy v krovi cheloveka [Methods for the determination of prekallikrein-kallikrein system in human blood]. Kyiv (in Russian).
Zlatnik, E. A., & Nikipelova, O. F. (2012). Regressija opuholi i lokal'nye immunenye reakcii pri razlichnyh sposobah vvedenija ronkolejkina v jeksperimente [Tumor regression and local immune responses in various ways of administering Roncoleukin in the experiment]. Nauchnye Vedomosti. Serija Medicina, Farmacija, 129(10), 147–151 (in Russian).
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.